Dopamine depletion results in increased neostriatal D2, but not D1, receptor binding in humans

Molecular Psychiatry

Volumn 7, Issue 3, 2002, Pages 322-328

  Verhoeff, N P L G ^a,b   Tauscher, J ^b,c   Jones, C ^b   Hussey, D ^b   Lee, M ^b   Papatheodorou, G ^b   Wilson, A A ^b   Houle, S ^b   Kapur, S ^b  

^a Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Dopamine; Dopamine D1 receptors; Dopamine D2 receptors; In vivo binding; Positron emission tomography; 11C raclopride; 11C SCH23390; methyl para tyrosine

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CARBON 11; CATECHOLAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HOMOVANILLIC ACID; METIROSINE; NORADRENALIN; RACLOPRIDE;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; DOPAMINE BLOOD LEVEL; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NEOSTRIATUM; OUTCOMES RESEARCH; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0036214578     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001057     Document Type: Article

References (44)

1. 2 receptor occupancy by endogenous dopamine in humans
2. 2 receptors by dopamine in schizophrenia
3. 2 receptors by dopamine in vivo in healthy subjects
4. 1 receptors in schizophrenia revealed by PET
5. 1 receptors in schizophrenia predicts poor working memory performance
6. 1 dopamine receptor binding in mood disorders measured by positron emission tomography
7. 1 receptors in Parkinson's disease and striatonigral degeneration: A positron emission tomography study
8. 2 site binding in L-DOPA-treated Parkinson's disease patients with and without dyskinesias
9. Neuroimaging of dyskinesia
10. 1 receptor number - A sensitive PET marker for early brain degeneration in Huntington's disease
11. 2 receptor binding in patients with Huntington's disease and other choreas. A PET study
12. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes
13. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease
14. The relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease
15. 11C]NNC 756
16. Reserpine-induced reduction of in vivo binding of SCH23390 and N-methylspiperone and its reversal by d-amphetamine
17. 3H]SCH23390 in vivo
18. 2 radiotracers
19. 1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists
20. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review
21. Vulnerability of positron emission tomography radiotracers to endogenous competition. New insights
22. 2 receptor occupancy by endogenous dopamine in healthy humans
23. 1 receptor tracer, in normal subjects
24. Effect of catecholamine depletion on lithium-induced long-term remission of bipolar disorder
25. 2 receptor occupancy by dopamine in human ventral and dorsal striatum
26. 1 antagonist SCH 23390 is not modified by changes in dopaminergic transmission
27. 11C]NNC 756
28. 2 short receptors and induces receptor sequestration
29. 2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5
30. 2 receptors in rodents
31. Metabolism of alpha-methyltyrosine in man: Relationship to its potency as an inhibitor of catecholamine biosynthesis
32. Quantitation of catecholamine metabolites by gas chromatography-mass spectrometry with selected ion monitoring
33. A gas chromatographic-mass spectrometric (GC-MS) assay for 3-methoxy-4-hydroxyphenylethyleneglycol and vanylmandelic acid in human serum
34. Gas chromatographic quantitation of methoxyamphetamine and three of its metabolites in plasma
35. 2 receptors
36. Simplified reference tissue model for PET receptor studies
37. 11C]raclopride studies
38. 11C]raclopride binding
39. Parametric imaging of ligand-receptor binding in PET using a simplified reference tissue model
40. A JAVA environment for medical image data analysis: Initial application for brain PET quantitation
41. 125I]iodosulpride, a highly selective ligand